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Abstract 
A powerful approach to studying the mechanisms of disease is through the use of transgenic 
models like Drosophila melanogaster. The Drosophila homologue of the human Down syndrome 
candidate gene, DyrklA, is minibrain (mnb). Studies have shown that mnb can participate in 
development of the Drosophila eye to control growth and survival through modification of insulin 
receptor signalling. Huntingtin-interacting protein 1 (Hip 1 ), which differentially interacts with the 
mutant and normal forms ofthe Huntington disease protein, huntingtin, has been shown to play a role 
in Drosophila neurogenesis. There are two naturally occurring versions of the Hipl protein, a full 
length version and a truncated version missing theN-terminal ANTH domain, referred to as 
Hipl~ANTH. As a biochemical interaction has been identified between Hipl and DyrklA/mnb, this 
study examines these two genes in Drosophila development. In this study the UAS-Ga/4 system was 
utilized to direct the expression of DyrkJA/mnb, Hipl and components of the insulin signalling 
pathway, akt andfoxol, in the developing dorsal notum and eye. While neither mnb nor foxol over-
expression has any effect, we found that over-expression of akt, a component of the insulin signalling 
pathway, increases the microchaetae density on the dorsal notum. The over-expression of mnb and 
Hipl in the eye have no effect on eye development. Under the sensitized growth conditions where 
the GMRGa/4 also drives the UASfoxoll transgene, the full length versions of Hipl show decreased 
bristle number and decreased ommatidia number while the truncated versions of Hipllacking the 
lipid-binding ANTH domain show decreased ommatidia number. Over-expression of mnb and Hipl 
together withfoxol show changes in eye development, indicating a possible interaction between 
these two genes. As these are genes in two completely different diseases, fmding how they interact 
could provide a key insight into finding therapies for neurodegenerative diseases. 
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Introduction 
Drosophila as a model organism 
A powerful approach to the study of mechanisms of disease is through the use of 
transgenic models. Notably, Drosophila melanogaster has many attributes that make it a 
valuable research tool, such as a rapid life cycle, large numbers of offspring and ease of 
maintenance, that make it ideal for genetic experimentation (Bier 2005). Approximately 
75% of known human disease genes have homologues in Drosophila (Bier 2005), which 
makes it possible to characterize the biological properties associated with the Drosophila 
homologues. Furthermore, many developmental processes have been conserved 
throughout evolutionary history, so study in Drosophila can provide insights into the 
mechanisms of similar processes in humans (Bier 2005). Specifically, Drosophila has 
been used to study developmental disorders, neurological diseases such as Alzheimer, 
Parkinson and Huntington disease, trinucleotide repeat disorders (such as dentatorubral 
pallidoluysian atrophy), and cancer (reviewed in Bier 2005; Sang and Jackson 2005). 
Given the diversity of studies that have utilized Drosophila, it is an excellent choice as a 
model organism in which to study homologues of disease genes. 
The UAS-Gal4 system in Drosophila 
The UAS-Gal4 system, a directed or ectopic expression system used to express 
genes, is one of many molecular and genetic techniques available to manipulate 
Drosophila (Phelps and Brand 1998). This system utilizes the yeast transcription factor 
gene, Ga/4, and its protein target sequence UAS (ypstream ~ctivating .s_equence) to drive 
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the expression of genes in specific cells and tissues at precise times throughout the life of 
the organism. These two genes are maintained in separate transgenic fly lines. When 
crossed, the target gene is activated in the progeny due to the Gal4 protein binding to the 
UAS element in the enhancer region of the target gene to induce transcription (Phelps and 
Brand 1998). The UAS-Ga/4 system will be utilized in this study to direct the expression 
of DyrklA/mnb, the Down syndrome candidate gene, Huntingtin-Interacting Protein 
1 and genes of the insulin receptor-signaling pathway, akt and foxo 1. 
Drosophila eye growth and differentiation 
The Drosophila eye normally contains a hexagonal pattern of 750-800 
ommatidia (light -sensing units) that is the product of a series of precise events that take 
place during development (reviewed in Bonini and Fortini 1999; Thomas and Wassarman 
1999; Baker 2001; Frankfort and Mardon 2002). Differentiation of the cells that 
comprise the adult eye begins in the mid-third instar in the eye imaginal disc. The 
morphogenetic furrow moves from posterior to anterior across the eye disc as 
progressively more anterior disk regions begin eye differentiation. Each ommatidia 
contain eight photosensitive neurons, or photoreceptors, for a total of over 6000 neurons 
in the eye. In addition, accessory cells, including four lens-secreting cone cells, two 
primary pigment cells, shared secondary and tertiary pigments cells, and a four-cell 
mechanosensory bristle organ comprise each ommatidia (reviewed in Bonini and Fortini 
1999; Thomas and Wassarman 1999; Baker 2001; Frankfort and Mardon 2002). As the 
mechanism of Drosophila eye development is highly reproducible and consistent, the eye 
is a very useful tool for the study of subtle abnormalities such as subtle defects in a single 
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cell type or fraction of cells of a certain type. Moreover, in the laboratory, the phenotype 
of the eye does not influence viability and fertility. 
Approximately two thirds of the 13,600 genes in Drosophila are required for eye 
development, with the vast majority of these being required for general cellular processes 
(Sang and Jackson 2005). The study of the Drosophila eye has proven to be a powerful 
means to investigate gene function and is used to study cell growth and differentiation, 
programmed cell death, and tissue patterning (Kramer and Staveley 2003; Kramer eta/. 
2003; reviewed in Thomas and Wassarman 1999; Frankfort and Mardon 2002; Sang and 
Jackson 2005). Given its ability to show subtle, yet significant results, the Drosophila 
eye is an important tool for studying the effects of gene expression. 
The Drosophila notum as a model of neurogenesis 
Microchaetae development on the dorsal no tum of flies is a measure of 
neurogenesis, as bristles are mechanosensory organs formed from proneural cells (Jan 
and Jan 1994). For the most part, the dorsal notum is a two dimensional sheet of sensory 
bristles called microchaetae, or small bristles, and macrochaetae, or larger bristles. In the 
first stages of neural development, the proneural genes are turned on in the proneural 
clusters, giving those cells the potential to become neural precursors. Within those 
proneural clusters, the cells compete with each other through the actions of neurogenic 
genes, including Notch, Delta and the enhancer of split gene complex, so that only a 
subset of the cells give rise to neural precursors. These neural precursors will eventually 
give rise to the mechanosensory bristle organs. Therefore, the number of sensory bristles 
formed on the dorsal notum can be correlated to the number of sensory neurons (Jan and 
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Jan 1994). Although not as widely used as the eye, the dorsal noturn has been used to 
study the Notch signaling pathway genes (Ramain et a/. 2001) as well as the effects of 
Hip] gene expression on neurogenesis (Moores eta/. 2008). With its regular pattern of 
macrochaetae and microchaetae, the Drosophila dorsal notum is a reliable means to study 
neurogenests. 
Down syndrome: Characteristics of the disease 
Down syndrome (DS) is a neurogenerative disorder affecting one in 700 live 
births and is the most frequent cause of mental retardation in hwnans (Jacobs et al. 1959; 
Coyle et al. 1986). Individuals with DS typically have a reduction in brain size and brain 
weight, reduction of neurons in the cerebellum and the hippocampus, reduction of the 
cholinergic neurons of the basal forebrain and the granular layers of the cerebral cortex, 
and several abnormal neuronal differentiation processes (Guimera eta/. 1996). In 
addition to neuronal defects, DS patients have congenital heart abnormalities, seizure 
disorders, low muscle tone, gastrointestinal malformations, defects of the endocrine and 
immune system, increased rate of leukemia and early onset Alzheimer disease (Coyle et 
a/. 1986; Korenberg et al. 1994). Given the prevalence and severity of this condition, the 
genetic and molecular causes of this condition must be fully understood. 
Down syndrome: Genetic causes 
DS is the result of a total or partial triplication of human chromosome 21. Studies 
of rare cases of partial trisomy of chromosome 21 have resulted in the identification of a 
small section of this chromosome, 21 q22.2, known as the "Down syndrome critical 
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region" (DCR-1), which is responsible for the phenotypes commonly observed in DS 
patients (Delabar et al. 1993; Antonarakis 2001). One of the best studied candidate genes 
located in DCR-1 is the "gual specificity tyrosine phosphorylation-regulated kinase", or 
"gual-specificity Y AK1-related kinase A", DyrklA, and this gene has been investigated 
in brain function and development (Guimera eta/. 1996). Studies of the role of DyrklA 
is a promising avenue of research to understand the mechanisms underlying Down 
syndrome. 
Identification and nomenclature of DyrklA/mnb 
The acronym "Dyrk1A" refers to the ability of this family ofkinases to 
phosphorylate serine/threonine and tyrosine residues and to sequence similarity with the 
protein kinase Y AK1 from Saccharomyces cerevisiae (Becker and Joost 1999). In 
addition to the kinase domain, DyrklA contains a stretch of histidine repeats and a 
nuclear localization signal (Becker and Joost 1999). The first vertebrate Dyrk1A was 
identified in rodent models using a polymerase chain reaction (PCR) cloning method 
specific to the protein kinases (Kentrup et al. 1996). The human version of the gene was 
discovered by screening a human eDNA library with a putative exon isolated using an 
exon-trapping method, and verified to be a DyrklA gene based upon sequence similarities 
with the rat and Drosophila versions (Shindoh et al. 1996). The highly conserved nature 
of Dyrkl A suggests the importance of this gene in normal development. 
The Drosophila homologue of the human DyrklA is minibrain (mnb), the first 
member of the Dyrk family discovered. The mnb gene was identified in Drosophila 
through analysis of the mnb mutations, named due to the phenotypic "smaller brain" in 
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adult mnb mutants and was characterized by positional cloning (Tejedor eta/. 1995). The 
human and Drosophila versions of the mnb protein exhibit a 75% amino acid sequence 
similarity (Shindoh et al. 1996). Although mnb was first described over a decade ago, 
very little research has been described in Drosophila since then. 
DyrklA/mnb interacts with a large number of proteins 
Phosphorylation is an important mechanism of signal transduction in eukaryotic 
cells (Becker and Joost 1999). Dyrk1A/mnb' s ability to catalyze tyrosine-directed 
autophosphorylation and proline-directed phosphorylation of serine/threonine residues on 
exogenous substrates allows it to act with a high degree of versatility and substrate 
specificity. Dyrk1A/mnb has been shown to phosphorylate substrates in the nucleus such 
as ST AT3 ~ignal transducer and ~ctivator of transcription l) (Matsuo et a/. 2001 ), cyclin 
L2 proteins (de Graaf eta/. 2004), chromatin remodeling factors, SNR1 and TRX 
(Kinstrie eta/. 2006), and the splicing factor SF3bl/SAP155 (de Graaf eta/. 2006). In 
addition, the transcription factor Arip4 (~drogen receptor-interacting .Qrotein 1) (Sitz et 
a/. 2004) and the eukaryotic protein-synthesis initiation factor eiF2BE ~ukaryotic 
initiation factor 2Bepsilon) (Woods eta/. 2001a) are phosphorylated by Dyrk1A/mnb. 
Dyrk1A/mnb induces cAMP response element (CRE) mediated gene transcription by 
activating c-AMP response element binding protein (CREB) (Yang eta/. 2001), Glil 
(Mao et al. 2002), the forkhead transcription factor, foxo1 (Woods eta/. 2001b), and the 
NFAT (nuclear factor of activated T cells) family of transcription factors (Gwack et al. 
2006), suggesting a role for DyrklA/mnb in gene expression. Proteins in the cytoplasm 
including 14-3-3 (Kim et al. 2004), glycogen synthase (Skurat and Dietrich 2004), 
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dynamin (Chen-Hwang eta/. 2002), and the brain specific protein, PAHX-APl 
(phytanoyl-CoA a-hydroxylase associated protein 1) are also phosphorylated by 
DyrklA/mnb (Bescond and Rahmani 2005). DyrklA/mnb also interacts with tau, a 
microtubule-associated protein (Woods eta/. 2001a). This broad range of interactions 
suggests that DyrklA/mnb may be involved in numerous signaling pathways in vivo. 
DyrklA/mnb studies in vertebrates 
An extra copy of Dyrkl Almnb is hypothesized to play a major role in the 
developmental anomalies associated with DS (Wegiel eta/. 2004). DyrklA/mnb is 
expressed in regions of the embryonic and adult rat brain that include the cerebellum, 
cerebral cortex, hippocampus and brain stem, as well as the heart (Okui et a/. 1999; Marti 
eta/. 2003). Northern blot analysis with mRNA from human and mouse fetal brain tissue 
revealed that Dyrkl Almnb is over-expressed in the fetal DS human brain as well as in a 
mouse model ofDS (Guimera eta/. 1999). In the developing and adult human brain, 
DyrklA/mnb was found in the nucleus and cytoplasm of neurons (Wegiel eta/. 2004). 
The presence of Dyrkl Almnb in the nucleus suggests that it may play a role in the control 
of gene expression. In mouse brain development, the first wave of DyrklA/mnb 
expression participates in the transition of neural progenitor cells from proliferating to 
neurogenic divisions. This suggests that DyrklA/mnb plays a role in the neurogenesis of 
the vertebrate brain (Hammerle eta/. 2002). A second wave of DyrklA/mnb expression 
occurs in intermediate and late stage embryos during dendritic tree differentiation. In 
these stages, DyrklA/mnb expression is initiated by the translocation from the cytoplasm 
to the nucleus and then movement to the growing dendritic tree where the DyrklA/mnb 
7 
protein co localizes with dynamin 1, a key protein in receptor-mediated endocytosis 
(Hammerle eta/. 2003). Murine models ofDS that over-express DyrkJA/mnb display 
motor, learning and memory deficits in behavioural studies that seem to recapitulate the 
cognitive defects observed in DS (Smith eta/. 1997; Branchi eta/. 2004; Martinez de 
Lagran eta/. 2004). Transgenic mice that contain only one copy of the DyrkJA/mnb gene 
show significant impairment in hippocampal-dependent memory tasks (Ahnet a/. 2006). 
These studies indicate a significant role for DyrklA/mnb in learning and memory. 
Mutant Dyrkl Almnb mice have a decrease in brain size and changes in neuron density in 
selected brain regions (Fotaki eta/. 2002). Alternatively, mice over-expressing 
DyrklA/mnb have an increase in brain weight (Branchi eta/. 2004). Collectively, all of 
these studies suggest that DyrklA/mnb is involved in the neuropathological changes seen 
in patients with DS. 
DyrklA/mnb studies in non-vertebrates 
The DyrkJA/mnb enzyme is highly conserved evolutionarily, showing structural, 
enzymatic and functional similarities in organisms as diverse as yeast and humans 
(Becker and Joost 1999). In Saccharomyces cerevisiae, the DyrkJA/mnb homologue is 
Yakl p , which negatively regulates cell growth by acting as an antagonist to the 
Ras/cAMP-dependent protein kinase pathway (Smith eta/. 1998). In Dictyostelium, 
YakA is needed for starvation-induced growth arrest and initiation of a developmental 
response, as well as to mediate developmental events and facilitate exit from the cell 
cycle (Souza, eta/. 1998). Three homologues of Dyrkl A/mnb have been examined in 
Caenorhabditis elegans termed mbk-1, mbk-2 and hpk-1; the first is the most similar in 
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amino acid sequence to Dyrk1A/mnb. Although the loss ofmbk-1 has no obvious defects, 
over-expression of mbk-1 causes behavioural defects in chemotaxis toward volatile 
chemoattractants, with the extent of the defects increasing with the gene dosage (Raich et 
a/. 2003). The conservation of the Dyrk1A/mnb gene in organisms as unrelated as yeast 
and humans is a testament to the importance of its function. 
mnb studies in Drosophila 
Adult central nervous system development in Drosophila melanogaster involves a 
precise pattern of neuroblast proliferation. The Dyrk1A/mnb gene has been found to play 
a role in postembryonic neurogenesis by regulating the number and type of neurons that 
are formed. Flies with mutations in the Dyrk1 A/mnb gene have significantly reduced 
optic lobes and central brain hemispheres due to a decrease in the number of cells 
generated during the proliferative process (Tejedor eta/. 1995). This fmding is 
consistent with the fmding that mutant Dyrk1A/mnb mice have reduced brain size, and 
suggests a conserved mode of action determining brain size and normal growth in flies 
and mice (Lochhead eta/. 2003). The Dyrk1A/mnb mutant flies also show learning and 
memory defects (Tejedor eta/. 1995) similar to those found in humans (Coyle eta/. 
1986), showing the high conservation of the function of this gene in flies and humans. 
Previous studies using Drosophila as a model organism have shown that 
Dyrk1Aimnb participates in development of the Drosophila eye and controls growth and 
survival through modification of insulin receptor signaling (Rotchford and Staveley, 
unpublished). Flies with mnb mutations were found to be phenotypically similar (ie. 
smaller than normal adult size) to flies with mutations in akt and over-expression of 
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foxol. This showed that mnb is required for normal growth and may act through the 
foxol protein to regulate cell size. Finally, over-expression of mnb was found to suppress 
loss of bristles and ommatidia in the eye caused by foxo 1 over-expression, suggesting that 
mnb negatively regulatesfoxol (Ratchford 2006). 
Huntington disease: Characteristics of the disease 
Huntington disease (HD) is an autosomal dominantly inherited neurodegenerative 
disorder, affecting four to eight people per 100,000 (Harper 1992). Characteristic 
symptoms of the disease include cognitive, emotional and motor dysfunctions (Petersen 
eta/. 1999). Cognitively, patients experience decreases in mental processes, reduced 
mental flexibility, and disturbances in memory and intellectual ability, which lead to 
dementia. Depression and manic-depression may accompany cognitive disturbances. 
Motor function defects are the most common and well known features ofHD, and 
involve disturbances in both voluntary and involuntary movements. In addition, patients 
with juvenile HD have an increase rate of seizures, rigidity and tremors. Often patients 
display loss of body weight and muscle bulk. Symptoms often develop between the ages 
of 35 to 45, but age of onset can vary depending on the extent of genetic defect. In adult-
onset HD, death usually occurs within 15 to 20 years of onset. Juvenile cases progress 
faster, with death occurring in 7 to 10 years. Pathologically, there is a loss of the 
GABAergic medium-sized spiny neurons in the striatum and cortex of the brain. These 
neurons innervate the substantia nigra and globus pallidus (Petersen et a/. 1999). 
Aggregates ofN-terminal fragments of mutant huntingtin form in the nucleus and 
cytoplasm of neurons in the brain (DiFiglia et a/. 1997). The lack of treatment as well as 
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the great hardship for patients and their families highlights the importance of research on 
the mechanisms leading to HD. 
Huntington disease: Genetic causes 
HD is the result of an expanded CAG (cytosine, adenine, guanine) trinucleotide 
repeat in the gene huntingtin (htt), which encodes a protein of the same name whose 
routine function is relatively unknown (Ranen et a/. 1995). The htt gene is located on 
chromosome 4 and was isolated using restriction-fragment length polymorphism 
mapping (Petersen et al. 1999). The htt protein has an amino terminal poly glutamine 
(polyQ) stretch and mutant forms have an expanse ofQ's that is greater than 36 to 39 
residues in length. Below this pathogenic threshold, individuals are unaffected (Snell et 
al. 1993; Rubinsztein et al. 1997). However, there are some cases where individuals with 
36 to 39 repeats survive into old age without developing symptoms, suggesting that the 
HD mutation is not fully penetrant in some cases (Rubinsztein et al. 1997). Nevertheless, 
there is an inverse relationship between the age of onset and the severity of the disease 
with the number of residues present, such that repeats above 100 cause juvenile-onset of 
HD, whereas 40 to 50 residues are seen in adult-onset HD (Snell et al. 1993). High-
repeat-number alleles tend to undergo germline mutations that increase repeat number, 
leading to an increase in the length of the polyQ stretch from one generation to the next. 
This means that the disease can be present at earlier ages in successive generations 
(Rubinsztein et al. 1997). Although the proximate genetic cause is known, there are still 
many unanswered questions about the mechanism that leads to the trinucleotide 
repeat/polyQ stretch manifesting as HD. 
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Identification and studies of huntingtin 
The fmding that amyloid-like protein aggregates form in brains of the transgenic 
mouse model of HD led researchers to investigate this aspect of the pathology in humans 
(Scherzinger et a/. 1997). Nuclear inclusions had previously been found in HD patients, 
but they had not been investigated (Petersen et a/. 1999). This led researchers to perform 
immunohistochemical mapping of the striatal biopsies taken from HD individuals. The 
nuclear inclusions contained mutant forms of the huntingtin protein, which led to further 
research on this protein in the pathogenesis ofHD (Petersen eta/. 1999). 
Several research groups have established mouse models ofHD, such as a yeast 
artificial chromosome (Y AC) transgenic mouse containing an htt gene with 46 CAG 
repeats (Hodgson eta/. 1999). This mouse shows no behavioural defects or neuronal 
loss, but it does have a reduction in long-term potentiation in hippocampal sections. 
Another mouse model with 46 repeats shows striatal neuronal inclusions and 
hyperactivity (Laforet eta/. 1998). Additionally, invertebrate models, such as C. e/egans 
have been engineered to express polyQ expanded htt proteins, and show that htt 
fragments cause nuclear aggregation and neurodegeneration (Morley et a/. 2002). 
Studies on mice, rats, flies, C. elegans and pu:fferfish suggest that the gene is highly 
conserved, indicating an important cellular function (Sharp and Ross 1996). Many 
studies have shown a role for huntingtin in vesicle trafficking in which both normal and 
mutant huntingtin associate with clathrin-coated vesicles (V elier et a/. 1998). Mutant htt 
forms aggregates that impede the function of the endocytic pathway (Qin eta/. 2004). 
Despite these studies, the role ofhtt is not well understood and proteins that interact with 
it are under investigation. 
12 
Studies of huntingtin in Drosophila 
There are a number of Drosophila models of poly glutamine expansion disease 
which display cell death and protein aggregation much like that seen in human HD 
patients (reviewed in Rubinsztein 2002). These models show declined motor 
performance, decreased flying ability and a reduced survival rate (Romero eta/. 2008). 
Drosophila models have shown that polyglutarnine proteins can cause defects in axonal 
transport (Gunawardena eta/. 2003) and induce neuronal degeneration ofphotoreceptors 
(Jackson eta/. 1998) that occurs over a period of about 20 days (Romero eta/. 2008), or 
about two-thirds of a fly's life cycle. Attempts to find treatment for HD have been made 
using Drosophila as a model. Drosophila models of HD have been used to identify 
compounds that may be used as protein aggregation inhibitors (Desai eta/. 2006). 
Lithium and rapamycin used in combination show greater protection against 
neurodegeneration in Drosophila than either treatment used on its own (Sarkar et a/. 
2008). Finally Drosophila models of HD can be used to test the effectiveness of drug 
combinations as testing is rapid and potentially theurapeutic compounds can be 
administered in low doses, decreasing costs (Agrawai eta/. 2005). Drosophila models of 
HD have proven to be effective models for testing the development of HD pathology as 
well as methods for treating the disease. 
Huntingtin-interacting proteins 
Understanding the functions of proteins that interact with htt may help clarify the 
cellular mechanisms by which poly glutamine expansion of the htt protein manifests as 
HD. The fust of the huntingtin-interacting proteins discovered was huntingtin-associated 
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protein (Hap1) (Li et a/.1995). Hap1 could play a role in HD as its expression is higher 
in the brain than in other tissues. However, it is found in areas of the brain that are not 
affected in HD and the interaction ofHap1 with htt is increased with increased 
polyglutarnine expansion. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
interacts with both normal and mutant huntingtin (Burke et a/. 1996). GAPDH is a 
multifunctional enzyme that plays a role in glycolysis, DNA repair, and replication and 
endocytosis. GAPDH directly interacts with the polyglutamine tail ofhuntingtin. 
Huntingtin-interacting protein 2 (Hip2) was identified as a ubiquitin-conjugating enzyme, 
which may play a role in the ubiquitination of huntingtin (Kalchman eta/. 1996). 
Although Hip2 is expressed in the brain regions affected in HD, there is no correlation 
between the length of poly glutamine residues and the extent of binding of Hip2. 
Huntingtin has been show to form a complex with calmodulin (Bao eta/. 1996). Normal 
huntingtin binds to calmodulin in a calcium-dependent manner, but mutant huntingtin has 
been demonstrated to not require calcium to interact with calmodulin. 
Huntingtin-interacting protein 1 (Hip1) is perhaps the most interesting protein that 
binds to htt, due to its differential binding to normal and mutant htt (Kalchman et al. 
1997; Wanker eta/. 1997). Binding ofHip1 to huntingtin is reduced dramatically with 
polyglutamine expansion. The interaction between Hip 1 and htt presumably occurs at the 
membrane, as both proteins are found bound there (Kalchman eta/. 1997). Hip] is 
predominantly expressed in the central nervous system, and co localizes with htt in 
neuronal cells and clathrin-coated vesicles (Kalchman eta/. 1997; W anker et a/. 1997). 
Hence, Hip] is a strong candidate to reveal functional differences in normal and mutant 
htt. 
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Hipl characterization 
Hip1 is a 120kDa protein (Gervais et al. 2002) identified through a yeast-two 
hybrid screen because it binds to the amino terminus ofhuntingtin (Kalchman et al. 
1997). Through comparative genomic analyses, Hipl was shown to have 45% amino 
acid sequence similarity to Sla2p (synthetic lethal with actin binding protein [ABP] 1), 
the cytoskeletal assembly gene of S. cerevisiae (Holtzman et al. 1993). Sla2p encodes a 
protein involved in vesicle trafficking, endocytosis and cortical actin cytoskeleton 
formation. In addition, Hip] is homologous to the Caenorhabditis elegans gene, 
ZK3 70.3, a gene of unknown function (Morley et al. 2002). The three proteins, Hip] , 
Sla2p and ZK370.3, have similar molecular masses and carboxy-terminal domains 
(Kalchman et al. 1997). Hip 1 has four domains, an AP-180 N-terminal homology 
domain (ANTH), previously referred to as ENTH (~psin N-terminal homology domain), 
which allows the protein to interact with membranes that contain phosphatidylinositol 
4,5-bisphosphate (Ptdlns( 4,5)P2), a pseudo-death effector domain (pDED) for protein-
protein interactions, a central coiled-coil domain for clathrin binding and targeting to 
clathrin coated vesicles, and a C-terminal talin-like domain that binds to actin (Engqvist-
Goldstein et al. 2001 ; Legendre-Guillemin et al. 2002; Hyun et al. 2004). This domain 
structure suggests that Hip 1 plays a role mediating interactions between the cell 
membrane and/or membrane-bound vesicles and the cytoskeleton (Chen and Brodsky 
2005). The complex structure of Hipl suggests that the Hip1 protein has complex 
functions and knowing the structure of Hip 1 and functions of its domains may provide 
clues to the mechanisms that give rise to HD. 
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Hipl functions in cell death, cell growth and endocytosis 
Hip 1 has been identified as a pro-apoptotic protein as over-expression leads of 
Hipl to caspase-dependent cell death (Hackam eta!. 2000). Furthermore, Hip1 contains 
a domain that has a sequence homology to the death effector domains found in other pro-
apoptotic proteins. When expressed alone in tissue culture, the pDED of Hipl is 
sufficient to cause cell death, indicating the role of this domain in apoptosis. 
Interestingly, the severity of Hip 1 toxicity is increased with a longer poly glutamine tail 
(Hackam et a!. 2000). Poly glutamine expansion may cause the release of Hip 1 to 
activate apoptosis in striatal neurons in a caspase-dependent manner. This theory is 
supported by the finding that the main pathological defect in HD patients is the loss of 
medium spiny neurons in the striatum (Gervais eta!. 2002). Alterations in Hipl 
expression can lead to death of cells, much like the loss of neurons observed in HD 
brains. 
Hipl has been implicated as a contributor of tumour formation and growth. 
Expression of Hip] has been found in many primary human epithelial cancers, including 
breast, colon and prostate cancer, and is correlated with increasing aggressiveness of 
prostate cancer (Rao eta!. 2003). Clearly, Hip] plays a significant role in the balance 
between cell death and the uncontrolled growth seen in cancer. 
Hip 1 has been found to participate in receptor-mediated endocytosis by promoting 
clathrin-coated vesicle assembly (Chen and Brodsky 2005). Clathrin-coated vesicles are 
important for selectively transporting proteins for receptor mediated endocytosis, a 
process that ensures the fast and specific retrieval of synaptic vesicle membranes. The 
clathrin molecule has a triskelion shape and is composed of both heavy and light clathrin 
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chains (Chen and Brodsky 2005). Trimerized heavy chains, each with a covalently-
bound light chain, form polyhedral lattice-coated triskelia. Typically, proteins affect 
receptor-mediated endocytosis by influencing coat assembly, membrane association, 
membrane fission and uncoating by binding to heavy chains (Chen and Brodsky 2005). 
Hip1 has been identified to bind to the clathrin adapter protein (AP2) and the clathrin 
heavy chain (Metzler eta/. 2001 ). The light chains function to prevent spontaneous 
assembly and promote controlled assembly by other regulatory proteins. Hip 1 is one of 
the proteins that bind to light chains (Chen and Brodsky 2005). In addition, because 
Hip1 binds both clathrin and Ptdlns (4, 5) P2, it is thought to link the triskelia to the lipid 
membrane (Metzler et al. 2001 ). According to these studies, Hip 1 certainly plays a role 
in receptor-mediated endocytosis, but the specific function of Hip 1 has not yet been 
described in detail. 
Study of Hipl in Drosophila 
To facilitate the biological characterization of Hipl, the Drosophila homologue of 
Hipl was isolated in our laboratory (Moores et al. 2008). Compared to humans, the 
Drosophila genome has a highly conserved Hip] gene that contains the AP180 N-
terminal homology (ANTH) domain, pseudo death effector domain (pDED) and the talin-
like domain. There are two versions of the putative protein, a full length version and an 
alternative transcript that yields a version missing theN-terminal ANTH domain, referred 
to as Hip1MNTH. Hipl regulates neurogenesis in flies as revealed by microchaetae 
analysis in the adult dorsal no tum (Moores et al. 2008). While over-expression of full 
length Hip] decreases microchaetae bristle formation, the MNTH version, presumably 
17 
acts to interfere through an inhibitory activity act, produces increased bristle density on 
the no tum (Moores eta/. 2008).. Since the number of bristles can be correlated to the 
number of sensory bristles formed, this indicates a dual-regulatory role for Hip] in 
neurogenesis (Ramain et al. 2001; Moores eta/. 2008). The mechanism by which Hip] 
influences neurogenesis seems to be through the non-canonical Notch signaling pathway, 
where deltex appears to have the greatest influence (Moores et al. 2008). The study by 
Moores et al. was the first account of a role for Hip] in neurogenesis. 
A link between Hipl and DyrklA/mnb 
A biochemical interaction has been identified between Hip] and DyrkJA/mnb 
using the yeast two-hybrid assay (Kang et al. , 2005). During neuronal differentiation of 
embryonic hippocampal neuroprogenitor H19-7 cells, DyrklA/mnb selectively bound to 
and phosphorylated Hipl , which was induced by the addition ofbFGF, a fibroblast 
growth factor. Strong complexes formed between Hipl and DyrklNmnb. The binding 
of these two proteins resulted in blockage ofHipl-induced cell death and contributed to 
neurite outgrowth. Upon the addition of etoposide phosphate, the binding decreased and 
phosphorylation ofHipl diminished. No longer bound to DyrklA, Hipl was free to bind 
to caspase-3 to activate cell death. On the basis of a clear, functional interaction 
established in tissue culture cells, the current study aims to investigate the biological 
interaction between the DyrkJA/mnb, and Hipl in Drosophila melanogaster as a model 
orgarusm. 
18 
Goals of this research 
This project will utilize Drosophila melanogaster to study the biological effects 
ofmnb and Hipl gene expression. Experiments that examined DyrklA/mnb ectopic 
expression in Drosophila have shown that DyrklA/mnb controls growth through 
modification of insulin receptor signaling (Rotchford 2006; Rotchford and Staveley, 
unpublished). The first goal of the current study is to investigate a potential role for 
components of the insulin receptor pathway and Dyrkl Almnb in neurogenesis. 
Specifically, I will direct the expression of these genes using the pannier- and apterous 
Ga/4 lines to the dorsal notum and perform biometric analysis on the tissue. Second, 
previous studies in our laboratory have characterized the role of the two versions of the 
Hipl protein, a full length version containing a lipid-binding domain, and a truncated 
version lacking the lipid-binding domain, Hip 1 MNTH, in Drosophila neurogenesis 
(Moores et al. 2008). My goal is to analyze the effect of Hipl on eye development by 
directing the expression of Hipl to the developing eye using the GMR transgene and 
performing biometric analysis. Finally, as a biochemical link has been made between 
mnb and Hip 1, the biological consequences of aspects of this proposed interaction will be 
studied in the Drosophila eye by expressing the mnb and Hipl genes together in afoxol-
sensitized background and analyzing the eyes biometrically. Using the Drosophila model 
will allow the characterization of subtle alterations in the development and growth of the 
adult eye and notum. 
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Materials and Methods 
Investigating the role of mnh, akt, andfoxol in neurogenesis 
Drosophila stocks 
They w; apterousGa/4/CyO ( apGa/4) and y w; pannierGal4/TM3, UAS, y + 
(pnrGa/4) transgenics (Calleja et al. 1996) were obtained from Bloomington Drosophila 
Stock Center (University oflndiana, Bloomington). They w67c23 mnbEYl4JlO (UASmnb) 
(Bellen eta/. 2004) stocks were created by members of the Drosophila Gene Disruption 
Project and provided by Bloomington Drosophila Stock Center. Thew; UASAkt u/CyO 
line (UASakt) was described in Staveley eta/. (1998), and the inducible murinef oxol 
homologue, w; UASfoxol/CyO (UASfoxo) was described in Kramer et al. (2003). Thew; 
UASlacz4·1-2 (UAS/acZ) (Brand and Perrimon 1994) and thew; UASGFP (UASGFP) 
(Y eh et al. 1995) control lines were obtained from the Bloomington Drosophila Stock 
Center. Table 1 summarizes these genotypes, their sources, and abbreviations used 
throughout the thesis. 
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Table 1. The genotypes of stocks used to study the potential role of mnb, akt, and 
foxol in neurogenesis, their sources, and abbreviations used throughout the thesis. 
Full Genotype Reference Abbreviation 
Transgenic transcription 
factors 
y w; apterousGa/4/CyO Calleja et a/. 1996 apGa/4 
y w; pannierGal4/TM3 UAS, y + Calleja et al. 1996 pnrGa/4 
Control genes 
w; UASGFP Yeh eta/. 1995 UASGFP 
w· UAS/acz4-l-l 
' 
Brand and Perrimon 1994 UAS/acZ 
Experimental genes 
y w67c23 mnbEY/4320 Hellen et al. 2004 UASmnb 
w; UASAkt 1·1/CyO Staveley et a/. 1998 UASakt 
w; UAS(oxol/CyO Kramer et a/. 2003 UASfoxol 
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Drosophila culture 
To investigate the roles of mnb and components of the insulin signaling pathway, 
akt andfoxol , in neurogenesis, four to six males carrying the UASmnb, UASakt, and 
UASfoxol responsive genes were each crossed to eight to ten virgin females of the 
apGa/4 and pnrGa/4 fly lines. Control crosses were set up using four to six males of 
UASlacZ and UASGFP, which were crossed to eight to ten virgin females from both the 
apGa/4 and pnrGa/4 fly lines. Crosses were maintained on standard cornmeal yeast 
molasses agar media at 25°C. Parental flies were transferred to fresh media after four 
days to increase production of progeny. Critical class males and females were collected 
based on an absence of CyO for apGa/4 crosses and TM3; UAS, y + for pnrGa/4 crosses 
(Figure 1 and 2). Critical class individuals were aged in fresh vials for three to five days, 
then placed in 1.5 mL microcentrifuge tubes and frozen at -70°C. 
22 
Go: a. w; UAS/acZ 
b. w; UASGFP X y w; apterousGa/4/CyO ~ 
c.ywUASmnb 
d . w; UASAkt 1·1/CyO 
e. w; UASfoxo1/CyO 
a. w; UAS/acZ /apGa/4 
G1: 
b. w; UASGFP/apGa/4 
c. y w UASmnb ; apGa/4 * 
d. w; UASAkt 1·1/apGa/4 
e. w; UASfoxo1/apGaJ4t 
Figure 1. Schematic diagram of crosses made to examine the potential effects of 
mnb, akt andfoxol on neurogenesis using the apterousGa/4 transgene. Crosses to 
UASlacZ (a) and UASGFP (b) were conducted as controls. Experimental crosses were 
performed for UASmnb (c), UASakt (d) and UASfoxol (e). tNote: no critical class 
offspring were recovered from this cross. * Note: only female progeny were collected 
from this cross. 
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Go: a. w; UAS/acZ 
b. w; UASGFP X y w; pannierGa/4/TM3, UASy+ ~ 
c.ywUASmnb 
d . w; UASAkt 1·1/CyO 
e. w; UASfoxo1/CyO I 
G1: a. w; UAS/acZ; pnrGa/4 
b. w; UASGFP; pnrGa/4 
c. y w UASmnb ; pnrGa/4 • 
d. w; UASAkt 1·11+; pnrGa/4 
e. w; UASfoxo1/+; pnrGa/4 
Figure 2. Schematic diagram of crosses made to examine the potential effects of 
mnb, akt, andfoxol on neurogenesis using the pannierGal4 transgene. Crosses to 
UASlacZ (a) and UASGFP (b) were conducted as controls. Experimental crosses were 
performed for UASmnb (c), UASakt (d) and UASfoxol (e). *Note: only female progeny 
were collected from this cross. 
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Biometric analysis of dorsal notum microchaetae 
The density of microchaetae on the dorsal notum has been characterized in Notch 
mutants as a measure ofneurogenesis (Ramain et al. 2001). Flies were mounted on 
aluminum scanning electron microscope studs with the dorsal notum facing upward. 
Studs were desiccated overnight and then gold coated using either a S 150 Gold Sputter 
Coater or an EMSK550 Gold Sputterer. Samples were photographed using a Hitachi 570 
scanning electron microscope or a FEI Quanta 400 environmental scanning electron 
microscope. Micrographs taken on the Hitachi 570 scanning electron microscope were 
photographed at 80X magnification, while those taken on the FEI Quanta 400 
environmental scanning electron microscope were photographed at 250 X magnification 
due to the differences in the calibrations of the microscopes. Micrographs were analyzed 
using Image J digital image analysis software (http://rsbweb.nih.gov/iiD (Abramoff et al. 
2004). The number ofmicrochaetae on the dorsal notum were counted for each image. 
Total dorsal notum area (f..Lm2) was also calculated. The microchaetae counts and notum 
area were used to calculate the bristle density, expressed as number of microchaetae per 
100 f..LID2. Bristle density values were exported into the GraphPad Prism 4 program (by 
GraphPad Software, Inc.) and mean ± standard error of the mean (SEM) are plotted for 
each individual genotype. Males and females were analyzed separately due to expected 
phenotypic differences in size. Groups were subjected to a one-way ANOV A analysis 
with Neuman-Keuls post-tests, using GraphPad Prism 4, to determine significance 
between pairs. 
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The potential role of H untingtin interacting protein-1 and minibrain in eye 
development using GMRGa/4 
Drosophila stocks 
The UASmnb stock was described above. The two independent isolates of the full 
length version of the Hipl gene, w; UCyO; UASHiplL-2/TMJ,Sb (UASHiplL-2) and w; 
UCyO; UASHipJL-6/TMJ,Sb, (UASHiplL-6) and the two isolates of the amino terminal 
truncated form of the Hip] gene, UASHipJ/1·2 and UASHipJ5·2 (referred to as Hip-
JLJANTH) were described in Moores (2006). Both full length versions of Hip] were 
crossed to w; Ly!TM6B (obtained from Staveley laboratory stock) to eliminate the second 
chromosome balancer. Male and female progeny with CyO and TM6B were backcrossed 
to each other to obtain w; UASHiplL-2trM6Band w; UASHiplL-6/TM6B lines (Appendix 
1). Thew; GMRGa/412 transgenic line was described in Freeman (1996). Table 2 
summarizes these genotypes and their sources. 
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Table 2. The genotypes of stocks used to study the potential role of Hipl, 
HiplMNTH and mnb in eye development, their sources, and abbreviations used 
throughout the thesis. 
Full Genotype Reference Abbreviation 
Transgenic transcription 
factors 
w; GMRGa/412 Freeman 1996 GMRGa/4 
Control genes 
w; UASGFP Yeh et al. 1995 UASGFP 
w · UAS/aczt-'-2 
' 
Brand and Perrirnon 1994 UASlacZ 
Experimental genes 
w; UASHiplL-2/TM6B Moores 2006 UASHiplL-2 
w; UASHiplL-6/TM6B Moores 2006 UASHiplL-6 
w; UASHipJ5·2 Moores 2006 UASHipJ5·2 
w; +; UASHipJ 11·2 Moores 2006 UASHipJ''·2 
y w67c23 mnbEY/4320 Bellen et al. 2004 UASmnb 
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Drosophila culture 
To examine the role of mnb in eye development, two to four males of UASmnb 
were crossed to six to eight virgin females of GMRGa/4. To investigate the role of both 
the full length and truncated versions of the Hipl gene on eye development, two to four 
males of UASHiplL-2, UASHiplL-6, UASHipJ 11·2 and UASHipJ5·2 1ines were each crossed 
to four to six virgin female GMRGa/4. Control crosses were conducted using two to four 
males of UASlacZ and UASGFP and four to six virgin females from the GMRGal4 line 
(Figure 3). Crosses were maintained at 25°C on standard cornmeal yeast molasses agar 
media. Parental flies were transferred to fresh media after four days to increase 
production of progeny. All progeny were collected for GMRGal4 crosses as there was no 
balancer chromosome to select against. Collected flies were aged in fresh vials for three 
to five days, placed in microcentrifuge tubes and frozen at -70°C. 
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Go: 
a. w; UAS/acZ X w; GMRGa/412 0 
b. w; UASGFP 
c. ywUASmnb 
d. w; UASHip1L·2JTM6B 
e. w; UASHip1L-6fTM6B 
'· w; UASHip15·2 
g. w; UASHip111·2 
I 
G1: 
a. w; UAS/acZ/GMRGa/4 
b. w; UASGFP/GMRGa/4 
c. y w UASmnb; GMRGa/4 
d. w; GMRGa/4; UASHip1L-2 
e. w; GMRGa/4; UASHip1L-6 
t. w; UASHip15·2/GMRGa/4 
g. w; GMRGa/4; UASHip111.2 
Figure 3. Schematic diagram of crosses made to examine the potential effects of 
Hipl, HiplMNTH and mnb in eye development using the GMRGa/4 transgene. 
Crosses to UASlacZ (a) and UASGFP (b) were conducted as controls. Experimental 
crosses were performed for UASmnb (c), UASHiplL-2 (d), UASHiplL-6 (e), UASHipJ5·2 (f) 
and UASHipl 11·2 (g). 
29 
Biometric analysis of the adult eye 
Analysis of adult Drosophila eye structures has been used to reveal subtle aspects 
of growth and cell survival (for example Kramer eta/. 2003). Flies were mounted on 
aluminum scanning electron microscope studs using double sided sticky tape with the left 
eye facing upward. Studs were then desiccated overnight and gold coated using either a 
S150 Gold Sputter Coater or an EMSK550 Gold Sputterer. Eyes were photographed 
using a Hitachi 570 scanning electron microscope or a FEI Quanta 400 environmental 
scanning electron microscope. Micrographs taken on the Hitachi 570 scanning electron 
microscope were photographed at 170X magnification, while those taken on the FEI 
Quanta 400 environmental scanning electron microscope were photographed at 450X 
magnification due to differences in the calibration of the microscopes. Micrographs were 
analyzed using Image J digital image analysis software (http://rsbweb.nih.gov/iiD 
(Abramoff eta/. 2004). The number of ommatidia and number of bristles were counted 
for each image. The area (in J!m2) of seven ommatidia in a "honey comb" pattern was 
determined for three sets and the average area per ommatidia was calculated. Ommatidia 
number, bristle number and area of ommatidia values were exported into the GraphPad 
Prism 4 program (by GraphPad Software, Inc.) and means ± standard error of the means 
(SEM) were plotted for each of the three parameters for each individual genotype. Male 
and female flies were analyzed separately due to expected phenotypic differences in size. 
Using GraphPad Prism 4, groups were subjected to a one-way ANOVA analysis with 
Neuman-Keuls post-tests to determine significance between pairs and mean ± standard 
error of the mean (SEM) were plotted for each individual genotype. 
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Interaction offoxol with mnb and Hipl 
Drosophila stocks, culture and analysis 
Thew; GMRGa/4 UASfoxol/CyO (GMRGa/4 UASfoxol) recombinant line was 
described in Kramer et al. (2003). Additional stocks used were as above in "The 
potential role of Huntingtin interacting protein-] and minibrain in eye development using 
GMRGal4" section. To investigate the interaction offoxol with mnb and Hip] , two to 
four males of GMRGa/4 UASfoxol/CyO were crossed to six to eight virgin females of 
UASGFP, both versions of UASHipl, both versions of UASHipl!i.ANTH, and mnb. 
Crosses were maintained at 25°C on standard cornmeal yeast molasses agar media. 
Parental flies were transferred to fresh media every four days to increase production of 
progeny. Both male and female progeny were collected based on a lack of CyO (Figure 
4). Collected flies were aged in fresh vials for three to five days, placed in 1.5 ml 
microcentrifuge tubes and frozen at -70°C. Analysis was conducted as per above in the 
"Biometric analysis of dorsal no tum microchaetae" and "Biometric analysis of the adult 
eye" sections. 
31 
Go: a. w; UAS/acZ 
b.w; UASGFP 
X w; GMRGa/4UASfoxo1/CyO 0 
b.ywUASmnb 
c. w; UASHip1L·2fTM6B 
d. w; UASHip1L-6JTM6B 
e. w; UASHip15·2 
t. w; UASHip111·2 I 
G1: a. w; UAS/acZIGMRGa/4UASfoxo1 
b. w; UASGFP/GMRGa/4UASfoxo1 
b. y w UASmnb; GMRGa/4UASfoxo1 
c. w; GMRGa/4UASfoxo1; UASHip1L·2 
d. w; GMRGa/4UASfoxo1; UASHip1L·6 
e. w; UASHip15.2fGMRGa/4UASfoxo1 
r. w; GMRGa/4UASfoxo1; UASHip111.2 
Figure 4. Schematic diagram of crosses made to examine the potential effects of 
Hipl, HiplMNTH and mnb in eye development with the GMRGa/4 and UASfoxol 
transgenes. Crosses to UASGFP (a) were conducted as controls. Experimental crosses 
were performed for UASmnb (b), UASHip1~2 (c), UASHip1~6 (d), UASHipJ5·2 (e) and 
UASHipJ 11·2 (f). 
32 
Interaction of mnb and Hipl with each other 
Drosophila stocks 
Thew; UCyO; Ki!TMJ,Sb line was created and obtained from B. E. Staveley (Memorial 
University ofNewfoundland). Additional stocks used were as above. 
Generation of mnb; Hip] lines 
To investigate the possible interactions between mnb and Hip I, combinations of mnb 
transgenics with both versions of Hiplwere generated as follows: 
For Hipl on the third chromosome 
Eight to ten virgin females of UASmnb were crossed to four to six males of w; 
Ly/J'M6B. Males were selected with either Ly or TM6B and crossed to UASmnb virgin 
females. The UASmnb; Ly/+ progeny were crossed to UASmnb; +II'M6B progeny to 
obtain UASmnb; Ly/J'M6B flies. The UASmnb; Ly/J'M6B flies were then crossed together 
to establish a stock line that can be used in future crosses (Figure 5). Six to eight virgin 
females of UASmnb; Ly/J'M6B were crossed to four males of UAS HiplL-2, UAS Hipl L-6, 
and UAS Hip1 11.2. Male progeny was collected on the basis ofTM6B presence, and 
crossed back to virgins with mother-like genotype (UASmnb; Ly/J'M6B). Virgin females 
and males were collected on the basis of TM6B presence and crossed together to establish 
UASmnb; UASHiplL-2, UASmnb; UASHiplL-6 and UASmnb; UASHipJ 11·2 combination 
lines (Figure 6). 
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Go: ~ ywUASmnb X w; Ly/TM6B 
1 
G1: ywUASmnb X 
a. y w UASmnb; Ly/+ 0 
b. y w UASmnb; +/TM6B 
1 
G2: a. y w UASmnb; Ly/+ X b. y w UASmnb; +ITM6B 
1 
G3: y w UASmnb; Ly/TM6B X y w UASmnb; Ly/TM6B 
1 
Stock y w UASmnb; Ly/TM6B 
Figure 5. Schematic diagram of crosses made to establish UASmnb; Ly/l'M6B 
stocks to examine the potential interaction of Hipl and Hipl MNTH with mnb in eye 
development with the GMRGa/4 and UASfoxol transgenes. 
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a. w; UASHip1L-2fTM6B 
Go: ~ y w UASmnb; Ly/TM6B X b. w; UASHip1L-6fTM6B 
I c. w; UASHip111·2/TM6B 
~ y w UASmnb; Ly/TM6B X 
a. UASmnb; UASHip1L-2fTM6B 0 G1: 
I 
b. UASmnb; UASHip1L-6fTM6B 
c. UASmnb; UASHip111·2/TM6B 
a. UASmnb; UASHip1L-2fTM6B X a. UASmnb; UASHip1L-2fTM6B 
G2: 
b. UASmnb; UASHip1L-6fTM6B I b . UASmnb; UASHip1L-6fTM6B c. UASmnb; UASHip111·2fTM6B c. UASmnb; UASHip111·2/TM6B 
Stock a. UASmnb; UASHip1L-
2fTM6B 
b. UASmnb; UASHip1L-6JTM6B 
c. UASmnb; UASHip111·2/TM6B 
Figure 6. Schematic diagram of crosses made to establish UASmnb; UASHipl 
combination stock lines for Hipl on the third chromosome that will be used to 
examine the potential interaction of Hipl and Hipl MNTH with mnb in eye 
development with the GMRGa/4 and UASfoxol transgenes. 
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For Hip] on the second chromosome 
. 
Eight to ten virgin females of UASmnb were crossed to four to six males of w; 
VCyO; Ki!TM3, Sb. Males were selected with either V+; +ITM3, Sb or +/CyO; 
+ITM3,Sb and crossed to UASmnb virgin females. The UASmnb; U +; +ITM3,Sb 
progeny were crossed to UASmnb; +/CyO; +ITM3, Sb progeny to obtain UASmnb; 
VCyO; +ITM3,Sb flies. The UASmnb; VCyO; +ITM3, Sb flies were then crossed 
together to establish a stock line that can be used in future crosses (Figure 7). The 
UASmnb; VCyO; +ITM3, Sb flies were crossed to UASHipJ5·2• Male progeny was 
selected for CyO and TM3,Sb or CyO alone, and crossed back to virgins with mother-like 
genotype (UASmnb; VCyO; +ITM3,Sb). Virgin females and males were collected on the 
basis of CyO presence and crossed together to establish UASmnb; UASHipJ5·2 
combination lines (Figure 8). 
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Go: ywUASmnb X w;L/CyO;Ki/TM~Sb 
j 
0 
G1: ywUASmnb X a. y w UASmnb; Ll+; +/TM3, Sb b . y w UASmnb; +/CyO; +/TM3,Sb 
I 
G2: a . y w UASmnb; Ll+; +/TM3, Sb X b . y w UASmnb; +/CyO; +ITM3,Sb 
I 
G3: y w UASmnb; L/CyO; +/TM3, Sb X y w UASmnb; L/CyO; +/TM3, Sb 
I 
Stock y w UASmnb; L/CyO; +/TM3, Sb 
Figure 7. Schematic diagram of crosses made to establish UASmnb; VCyO; +/TM3, 
Sb stocks to examine the potential interaction of Hipl and Hipl MNTH with mnb in 
eye development with the GMRGa/4 and UASfoxol transgenes. 
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Go: y w UASmnb; UCyO; +/TM3, Sb X w; UASHip15·2 
I 
G1: IT y w UASmnb; UCyO; +,, M3, Sb X a. y w UASmnb; Hip1
5
·
2/Cy0; +/+ 0 
b. y w UASmnb; Hip15·2/Cy0; +/TM3,Sb 
I 
G2: y w UASmnb; Hip15·2/Cy0; +/+ X y w UASmnb; Hip15·2/Cy0; +/+ 
I 
Stock y w UASmnb; Hip15·2/Cy0; +/+ 
Figure 8. Schematic diagram of crosses made to establish UASmnb; UASHipl 
combination stock lines for Hipl on the second chromosome that will be used to 
examine the potential interaction ofHipl and HiplMNTHwith mnb in eye 
development with the GMRGa/4 and UASfoxol transgenes. 
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Drosophila culture and analysis 
To investigate the interaction of mnb and Hipl together withfoxol, two to four 
males of GMRGa/4 UASfoxol/CyO were crossed to six to eight virgin females of 
UASmnb; UASHiplL-2, UASmnb; UASHiplL-6, UASmnb; UASHipJ5·2 and UASmnb; 
UASHipl 1u. Crosses were maintained at 25°C on standard cornmeal yeast molasses 
agar media. Parental flies were transferred to fresh media at four days to increase 
production of progeny. Both male and female progeny were collected based on a lack of 
CyO (Figure 9). Collected flies were aged in fresh vials for three to five days, placed in 
1.5 ml microcentrifuge tubes and frozen at -70°C. 
Analysis was conducted as above. 
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Go: 
~ a. UASmnb; UASHip1L·2/TM6B 
X w; GMRGa/4UASfoxo1/CyO (J 
b . UASmnb; UASHip1L-6JTM6B 
c. y w UASmnb; Hip15·2/Cy0 
d. UASmnb; UASHip111·2/TM6B 
I 
G1: a. UASmnb; GMRGa/4UASfoxo1; UASHip1L·2 
b. UASmnb; GMRGa/4UASfoxo1; UASHip1L·6 
c. UASmnb; UASHip15·2/GMRGa/4UASfoxo1 
d. UASmnb; GMRGa/4UASfoxo1; UASHip111•2 
Figure 9. Schematic diagram of crosses made to examine the potential effects of 
Hipl and HiplMNTH with mnh in eye development with the GMRGa/4 and 
UASfoxol transgenes. Experimental crosses were performed for UASmnb; UASHiplL-l 
(a), UASmnb; UASHiplL-6 (b), UASmnb; UASHipJ 5·2 (c) and UASmnb; UASHiplll.l (d). 
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Results 
Investigation of neurogenesis in the dorsal notum 
there is no phenotypic effect of mnb on neurogenesis in the dorsal notum 
With the demonstrated role for Hipl in neurogenesis and the intriguing interaction 
between mnb and Hip] in cell culture, this study investigates the role of mnb on 
neurogenesis, usingpnrGa/4 and apGa/4 to direct the over-expression of genes 
throughout the dorsal notum. The expression of pannier is greatest at the midline and 
diminishes laterally while the expression of apterous is highest laterally and is lowest at 
the midline (Calleja et al. 1996). Microchaetae density per 100 Jlm2 was determined for 
electron micrographs of males and females of each genotype. As well, macrochaetae 
gross morphology was observed as well as differences in position and number on the 
dorsal notum. Results are summarized in Table 3. There was no statistically significant 
difference in microchaetae density in response to mnb by apterousGa/4 compared to 
controls in females based on a one-way ANOVA (Figure 10). Similarly, expression of 
mnb by pannierGa/4 in females showed no differences in microchaetae density compared 
to controls based on a one-way ANOVA (Figure 11). It should be noted that no 
statistically significant difference between the lacZ and GFP controls using either 
apterousGa/4 or pannierGa/4 based on a one-way ANOV A (Figures 10 and 11 ). Results 
are summarized in Table 3. There was no difference in the gross morphology, position or 
number of macrochaetae in response to mnb as shown in the electron micrographs in 
Figures 10 and 11. 
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Figure 10. Biometric analysis of a potential role of mnb in neurogenesis with the 
apterousGa/4 transgene in females. Directed expression of mnb in the dorsal notum has 
no phenotypic effect on rnicrochaetae density based on a one-way ANOV A (n=30). 
Micrographs of dorsal notums are shown in A. Graphic representations of microchaetae 
density is shown in B (values represent mean ± SEM). The genotypes are as follows: 
GFP UASGFP/apGa/4, lacZ UASlacZ/apGa/4, mnb UASmnbEY/4320/+; apGa/4/+. Note: 
GFP and lacZ controls are the same as those used for apterousGa/4 driving the 
expression of akt. 
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Figure 11. Biometric analysis of a potential role of mnb in neurogenesis with the 
pannierGa/4 transgene in females. Directed expression of mnb in the dorsal notum had 
no phenotypic effect on microchaetae density based on a one-way ANOV A (n=30). 
Micrographs of dorsal no turns are shown in A. Graphic representations of microchaetae 
density are shown in B (values represent mean ± SEM). The genotypes are as follows: 
GFP UASGFP/+; pnrGa/4/+, lacZ UASlacZI+; pnrGa/4/+, mnb UASmnbEY/4320!+; 
pnrGa/4/+ . Note: GFP and lacZ controls are the same as those used for pannierGa/4 
driving the expression of akt andfoxol. 
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akt over-expression affects neurogenesis in the dorsal notum butfoxol over-expression 
does not show a phenotypic effect 
The potential roles of akt and foxo 1, two well-studied insulin receptor signaling 
components, were investigated in neurogenesis. The pannierGa/4 and apterousGa/4 
transgenes were used to direct the over-expression of akt andfoxol throughout the dorsal 
notum. Microchaetae density was determined for electron micrographs of males and 
females except that in flies with apterousGa/4 drivingfoxol did not survive and could 
not be analyzed. As well, differences in gross morphology, position and number of 
macrochaetae on the dorsal notum were noted. There was no statistically significant 
difference, based on a one-way ANOVA, in microchaetae density in response to akt 
expression by apterousGa/4 compared to controls for either males or females (Figures 12 
and 13). Expression offoxol by pannierGa/4 showed no differences in microchaetae 
density compared to controls for males and females based on a one-way ANOV A 
(Figures 14 and 15). However, there was an increase in the microchaetae density with 
akt expression by pannierGa/4 compared to both the lacZ and GFP controls in females 
but not males. Although not different from the controls, the microchaetae density of 
female flies expressingfoxol withpannierGa/4 is significantly lower than the 
microchaetae density of flies expressing akt (Figure 14). Comparisons are summarized in 
Table 3. There was no difference in the gross morphology, position or number of 
macrochaetae in response to akt orfoxol expression under either transgene as seen in the 
electron micrographs shown in Figures 12 to 15. 
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Figure 12. Biometric analysis of a potential role of akt in neurogenesis with the 
apterousGa/4 transgene in females. Directed expression of akt in the dorsal notum has 
no phenotypic effect on microchaetae density based on a one-way ANOV A (n=30). 
Micrographs of dorsal notums are shown in A. Graphic representations of microchaetae 
density are shown in B (values represent mean ± SEM). The genotypes are as follows: 
GFP UASGFP/apGa/4, lacZ UAS/acZ/apGa/4, akt UASakt/apGa/4. Note: GFP and 
lacZ controls are the same as those used for apterousGa/4 driving mnb. 
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Figure 13. Biometric analysis of a potential role of akt in neurogenesis with the 
apterousGal4 transgene in males. Directed expression of akt in the dorsal notum has no 
phenotypic effect on microchaetae density based on a one-way ANOV A (n=30). 
Micrographs of dorsal notums are shown in A. Graphic representations of microchaetae 
density are shown in B (values represent mean± SEM). The genotypes are as follows: 
GFP UASGFPI+; pnrGa/4/+, lacZ UASlacZJ+; pnrGa/4/+, akt UASakt/+;pnrGa/4/+ . 
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Figure 14. Biometric analysis of a potential role of akt andfoxol on neurogenesis 
with the pannierGal4 transgene in females. Directed expression of foxo 1 in the dorsal 
notum has no phenotypic effect on microchaetae density based on a one-way ANOV A 
(n=20), while expression of akt increases microchaetae density compared to both GFP 
and lacZ controls (n=30) (p < 0.01 by Neuman-Keuls post-test). Micrographs of dorsal 
notums are shown in A. Graphic representations of microchaetae density are shown in B 
(values represent mean± SEM). The genotypes are as follows: GFP UASGFPI+; 
pnrGa/4/+, lacZ UASlacZI+; pnrGa/4/+, akt UASakt/+;pnrGa/4/+, foxol UASfoxoll+; 
pnrGa/4/+ . Note: GFP and lacZ controls are the same as those used for pannierGa/4 
driving mnb. Bars with dissimilar superscripts indicate groups that differ significantly. 
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Figure 15. Biometric analysis of a potential role of akt andfoxol in neurogenesis 
with the pannierGal4 transgene in males. Directed expression of akt (n=30) andfoxol 
(n=7) in the dorsal notum has no phenotypic effect on microchaetae density based on a 
one-way ANOV A. Micrographs of dorsal notums are shown in A. Graphic 
representations of microchaetae density are shown in B (values represent mean ± SEM). 
The genotypes are as follows: GFP UASGFPI+; pnrGa/41+, lacZ UASlacZI+; 
pnrGa/4/+, akt UASakt/+;pnrGa/4/+, foxol UASfoxol/+; pnrGa/4/+ . 
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Table 3. Comparison of microchaetae density changes in the dorsal notum in 
response to mnb, akt, andfoxol over-expression. 
Transcription 
Comparison factor Sex 
aktvs. GFP apterous F 
M 
aktvs.lacZ apterous F 
M 
foxo1 vs. GFP apterous F 
M 
foxo 1 vs. lacZ apterous F 
M 
aktvs. GFP pannier F 
M 
aktvs.lacZ pannier F 
M 
foxo1 vs. GFP pannier F 
M 
foxo 1 vs. lacZ pannier F 
M 
akt vs. foxo 1 apterous F 
M 
akt vs. foxo 1 pannier F 
M 
mnbvs. GFP apterous F 
mnb vs. lacZ apterous F 
mnbvs. GFP pannier F 
mnb vs.lacZ pannier F 
GFPvs.lacZ apterous F 
M 
GFPvs.lacZ pannier F 
M 
Arrows md1cate mcrease ( -t) or decrease (~) in treatment. 
p values based on Neuman-Keuls post tests 
~ 
~ 
~ 
NS= not significant F=female M=male 
Significance 
NS 
NS 
NS 
NS 
flies died 
flies died 
flies died 
flies died 
p < 0.001 
NS 
p < 0.001 
NS 
NS 
NS 
NS 
NS 
NA 
NA 
p < 0.01 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
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The potential role of Huntingtin interacting protein-] and mnb in eye development 
using GMRGa/4 
Hip] has no phenotypic effect on eye development under standard growth conditions 
As mnb has been found to play a role in eye development, the role of Hip] on eye 
development was investigated. The GMRGa/4 transgene was used to direct the over-
expression of genes throughout the developing eye. GMRGa/4 directs the expression of 
genes posterior to the morphogenetic furrow, a dorsoventral indentation, late in 
development (Freeman 1996). Ommatidia number, bristle number and ommatidia area 
were determined for electron micrographs of males and females. There was no difference 
within males or females in ommatidia number, bristle number or ommatidia area for 
either of the full length versions of Hip 1, Hip 1 L-2 and Hip 1 L-6 or the truncated versions of 
Hip], HiplMNTH5·2 or Hip1MNTH11·2, based on a one-way ANOVA (Figures 16 and 
17). Based on a one-way ANOVA, there was no difference between the two full length 
versions of Hipl or between the two truncated versions of Hipl (Figures 16 and 17). The 
controls, GFP and lacZ were not different in males or females based on one-way 
ANOVA, to suggest that either of these are good controls. Electron micrographs of eyes 
demonstrate the similarities among experimental conditions and controls (Figures 16 and 
17). 
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Figure 16. Biometric analysis of a potential role of Hipl and HiplMNTH on eye 
development using the GMRGa/4 transgene in females. Directed expression of two 
full length versions of Hipl, HiplL-2 and HiplL-6 and two truncated versions of Hip], 
Hip1MNTH5·2 and Hip1MNTH11·2• Hipl in the eye has no phenotypic effect on bristle 
number (n=lO), ommatidia number (n= lO) or ommatidia area (n=lO) compared to 
controls based on a one-way ANOV A. Micrographs of eyes are shown in A. Graphic 
representations of ommatidia area, bristle number and ommatidia size are shown in B 
(values represent mean± SEM). The genotypes are as follows: GFP 
UASGFP/GMRGa/4, lacZ UAS/acZIGMRGa/4, HiplL-2 UASHiplL-2/+; GMRGa/4/+, 
HiplL-6 UASHiplL-6/+; GMRGa/41+, Hip1MNTH5·2 UASHipJ5·2!GMRGal4, 
HiplMNTHn2 UASHipl/1. 2/+; GMRGa/41+. 
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Figure 17. Biometric analysis of a potential role of Hipl and HiplMNTH on eye 
development using the GMRGa/4 transgene in males. Directed expression of two full 
length versions of Hip] , Hipl L-2 and HiplL-6, two truncated versions of Hip] , 
HiplMNTH5·2 and HiplMNTH'1·2 have no phenotypic effect on bristle number (n= lO), 
ommatidia number (n=lO) and ommatidia area (n= lO) compared to controls based on a 
one-way ANOV A. Micrographs of eyes are shown in A. Graphic representations of 
ommatidia area, bristle number and ommatidia number are shown in B (values represent 
mean± SEM). The genotypes are as follows: GFP UASGFP/GMRGa/4, lacZ 
UAS/acZ/GMRGa/4, HiplL-2 UASHiplL-2/+; GMRGa/4/+, HipJL-6 UASHipl L-6/+; 
GMRGa/4/+, Hip1MNTH5"2 UASHipJ5·2!GMRGa/4, Hip1MNTH11·2 UASHipJu·2!+; 
GMRGa/4/+. 
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mnb has no phenotypic affect on eye development 
Studies in our laboratory have found that the over-expression of mnb along with 
foxol over-expression disrupts wild-type eye development (Rotchford 2006). However, 
the directed expression of mnb has not been carefully studied in eye development. This 
study utilized the GMRGa/4 transgene to direct the over-expression of mnb throughout 
the developing eye. Ommatidia number, bristle number and ommatidia area were 
determined for electron micrographs of females only. There was no difference in 
ommatidia number, bristle number for ommatidia area formed on the eye between 
experimental samples and controls based on one-way ANOVA (Figure 18). Electron 
micrographs show the similarity between mnb and control eyes (Figure 18). 
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Figure 18. Biometric analysis of a potential role of mnb in eye development using the 
GMRGa/4 transgene in females. The directed expression of mnb has no phenotypic 
effect on ommatidia area (n=IO), bristle number (n=IO), or ommatidia number (n=IO). 
Micrographs of eyes are shown in A. Graphic representations of ommatidia area, bristle 
number and ommatidia number are shown in B (values represent mean ± SEM). The 
genotypes are as follows: GFP UASGFP/GMRGa/4, lacZ UASlacZIGMRGal4, mnb 
UASmnbEYI43lO/+; GMRGa/4/+ . 
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Interaction offoxol with mnb and Hipl 
Hipl and Hiplt:L4NTH differentially affect eye development under conditions offoxol-
sensitized eye development 
Expression of mnb has been shown to rescue the phenotype caused by over-
expression offoxol by GMRGa/4 (Ratchford 2006), which results in a decrease in 
ommatidia number, bristle number and ommatidia area (Kramer eta/. 2003). To 
determine if Hip] interacts withfoxol , GMR-Ga/4 was used to direct the over-expression 
of murine foxol plus other genes throughout the developing eye and ommatidia area, 
bristle number and ommatidia number were measured. Results are summarized in Table 
4. Notably, directed expression ofthe truncated versions of Hipl , Hiplt:L4NTH5·2 and 
HiplMNTH11·2, and mnb in the eye along withfoxol, have no effect upon the ommatidia 
area in males or females (Figures 19 and 20). In males only, flies in which HiplL-2 and 
HiplL-6 were over-expressed had significantly lower ommatidia area than controls 
(Figures 19 and 20). There is no difference with respect to ommatidia area between the 
two truncated versions of Hip 1, but there is a difference in the full length versions of 
Hip] in males only (Figure 20). 
For flies in which Hipl L-2, HiplL-6, and mnb were over-expressed, there was a 
statistically significant decrease in bristle number compared to both lacZ and GFP 
controls (Figures 19 and 20). There is no difference in bristle number for the two 
truncated versions of Hipl , Hiplf:L4NTJf·2 and HiplMNTH11·2 compared to controls, 
with the exception of HiplMNTH5·2, which has increased bristle number compared to 
lacZ in females (Figure 19). There was no statistical difference between the two full 
length versions of Hip] , Hipl L-2 and HiplL-6, or between the two truncated versions of 
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Hipl , HiplMNTH5·2 and HiplMNTH11·2 in males and females in bristle number based 
on a one-way ANOV A. 
Flies over-expressing all of the Hipl genes produced fewer ommatidia than the 
controls with the exception of Hip] MNTH5·2 females which show no difference 
compared to /acZ controls (Figures 19 and 20). As well, mnb females had significantly 
lower ommatidida number than the GFP control only (Figure 19). There was no 
statistical difference when examining ommatidia number between the two full length 
versions of Hip] , Hipl~2 and HiplL-6, but there was a difference between the two 
truncated versions ofHip1, HipJMNTI-1·2 and HiplMNTH11·2 (Figures 19 and 20). 
There was no difference in the controls, GFP and /acZ for any condition observed 
(Figures 19 and 20). Electron micrographs of eyes demonstrate the differences in 
experimental genes compared to controls (Figures 19 and 20). 
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Figure 19. Biometric analysis of a potential role of Hipl, HiplMNTH and mnb in 
eye development along with the GMRGa/4 and UASfoxol transgenes in females. 
Directed expression of both full length versions of Hipl , HipJ L-2 and Hipl L-6, the 
truncated versions of Hipl, HiplMNTlf·2 and HiplMNTH11.2, and mnb effect eye 
development. Micrographs of eyes are shown in A. Graphic representations of 
ommatidia area, bristle number and ommatidia number are shown in B (values represent 
mean ± SEM). The genotypes are as follows: GFP UASGFPIGMRGal4UASfoxol , lacZ 
UASlacZJGMRGal4UASfoxol , HiplL-2 UASHipl&2/+; GMRGal4UASfoxoll+, HiplL-6 
UASHipJL-6/+; GMRGal4UASfoxol/+, HiplMNTH5·2 UASHipJ5·2!GMRGal4UASfoxol, 
HiplMNTHn2 UASHipl/1.21+; GMRGal4UASfoxol/+, mnb UASmnbEr14320!+; 
GMRGal4UASfoxoll+. Bars with dissimilar superscripts indicate groups that differ 
significantly. 
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Figure 20. Biometric analysis of a potential role of Hipl, Hipl MNTH and mnb on 
eye development along with the GMRGa/4 and UASfoxol transgenes in males. 
Directed expression of both full length versions of Hip] , HipJ L-2 and HipJL-6, the 
truncated versions of Hipl, Hip1MNTH5·2 and Hip1AANTH11·2, and mnb effect eye 
development. Micrographs of eyes are shown in A. Graphic representations of 
ommatidia area (n= lO), bristle number (n=IO) and ommatidia number (n= IO) are shown 
in B (values represent mean ± SEM). The genotypes are as follows: GFP 
UASGFP/GMRGal4UASfoxol , lacZ UAS/acZIGMRGal4UASfoxol , HiplL-2 UASHiplL-
21+; GMRGa/4UASfoxol/+, Hiplu UASHiplL-61+; GMRGa/4UASfoxol/+, 
HiplMNTH5·2 UASHipJ5·2!GMRGa/4UASfoxol, HiplMNTH11"2 UASHipJ 11·2!+; 
GMRGal4UASfoxol/+, mnb UASmnbErl4320/-. ; GMRGal4UASfoxoll+. Bars with 
dissimilar superscripts indicate groups that differ significantly. 
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Table 4. Comparison of differences in ommatidia area. bristle number 
and ommaditia number when mnb or HiplmiplAANTH is expressed along with 
foxol via the GMRGa/4 transgene. 
Ommatidia Bristle Ommatidia 
Comparison Sex Area Number Number 
Hip/ &1 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. GFP M ~ p < 0.001 ~ p < 0.0001 ~ p < 0.0001 
Hip! L-6 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. GFP M NS ~ g < 0.0001 ~ p < 0.0001 
Hip!AANTJf·1 F NS NS ~ p < 0.0001 
vs. GFP M NS NS ~ p < 0.0001 
HiplMNTH11"1 F NS NS ~ p < 0.01 
vs. GFP M NS NS ~ p < 0.01 
mnb F NS ~ p < 0.0001 ~ p < 0.01 
vs. GFP M NS ~ p < 0.0001 NS 
Hip/ L-1 F NS ~ p < 0.001 ~ p < 0.0001 
vs. lacZ M NS NS ~ p < 0.0001 
Hip! L-6 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. lacZ M ~ p < 0.0001 ~ p < 0.0001 ~ p < 0.0001 
HiplMNTlf·1 F NS 1'- p < O.ot ~ p < 0.0001 
vs. /acZ M NS NS ~ p < 0.0001 
Hip I MNTH11"1 F NS NS NS 
vs. /acZ M NS NS ~ p < 0.001 
mnb F NS ~ p < 0.001 NS 
vs. /acZ M NS NS NS 
Hip/ Lr1 F NS NS NS 
VS. Hipllr6 M .~. p < 0.0001 NS NS 
HipJMNTlf·1 F NS NS ~ p < 0.01 
vs. Hip 111ANTH11·1 M NS NS ~ p < O.OI 
Hipllr1 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. Hipl11ANTJf·1 M NS ~ p < 0.01 ~ p < 0.0001 
Hipllr6 F NS ~ p < 0.000 1 ~ p < 0.0001 
vs. HiplllANTlf·1 M ~ p < 0.0001 ~ p < 0.0001 ~ p < 0.0001 
Hipllr1 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. Hip 111ANTH11·1 M NS NS ~ p < 0.0001 
Hipllr6 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. HiplMNTHn2 M ~ p < 0.0001 ~ p < 0.0001 ~ p < 0.0001 
Hipl-1 F NS NS ~ p < 0.0001 
vs. mnb M NS NS ~ p < 0.0001 
Hipllr6 F NS NS ~ p < 0.0001 
vs. mnb M p < 0.0001 NS ~ p < 0.0001 
HiplAANTlf·2 F NS 1'- p < 0.0001 ~ p < 0.0001 
vs. mnb M NS NS ~ p < 0.0001 
Hipli1ANTHn2 F NS 1'- p < 0.0001 NS 
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vs. mnb M NS NS ~ p < 0.001 
GFP F NS NS NS 
vs. /acZ M NS NS NS 
Arrows indicate increase (1-) or decrease ·+· in treatment. ( )
p values based on Neuman-Keuls post-tests 
F= female M= male 
NS= not significant 
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Interaction of mnb and Hipl with each other 
The interaction between mnb and Hip] alters foxol sensitized eye development when 
compared to mnb withfoxol and Hip] withfoxol 
As mnb and Hip] have been found to interact withfoxol in the process of eye 
development and have been shown to interact biochemically, the interaction of mnb and 
Hip] with each other was investigated under the conditions ofjoxol-sensitized eye 
development. To determine if Hip] and mnb interact, GMR-Gal4 was used to direct the 
over-expression ofmurinefoxol plus other genes throughout the developing eye and 
ommatidia area, bristle number and ommatidia number were measured. A summary of 
these results can be seen in Table 5. Notably, when compared to Hip] withfoxol 
controls, Hip] and mnb together withfoxol increase ommatidia area for both full length 
versions, HipJL-2 and HiplL-6 and one truncated version of Hipl, HiplMNTHJJ·2 (Figures 
21 and 22). Compared to mnb andfoxol alone, Hipl and mnb together withfoxol 
increase ommatidia area for one full length version, HiplL-2, and one truncated version of 
Hipl, HiplMNTHJJ·2 (Figures 21 and 22). Differences in ommatidia area were found 
when comparing the two full length versions of Hip 1 with mnb and the two truncated 
versions of Hipl with mnb (Figures 21 and 22). 
Directed expression of Hipl with mnb andfoxol decreased bristle number for all 
versions of Hipl compared to the Hipl withfoxol controls (Figures 21 and 22). When 
compared to the mnb withfoxol control, both full length versions of Hipl were found to 
decrease the bristle number, whereas the truncated versions on Hip] increased the bristle 
number (Figures 21 and 22). In both males and females, there was no statistical 
difference when examining bristle number between the two full length versions of Hip] , 
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HiplL-2 and HiplL-6, or in females expressing the truncated versions ofHip1, but there 
was a difference between the two truncated versions ofHip1, Hiplfl.ANTH5·2 and 
Hip] MNTH11·2 in males (Figures 21 and 22). 
There was no significant difference in ommatidia number between the full length 
versions of Hipl with mnb andfoxol compared to Hipl withfoxol controls. (Figures 21 
and 22) Ommatidia number was increased in flies over-expressing the two truncated 
versions of Hip], Hip1MNTH5·2 and Hip1MNTH11·2compared to Hip1 withfoxol 
controls (Figures 21 and 22). When compared to mnb withfoxol controls, both the full 
length versions and one truncated version ofHip1 increased ommatidia number, while 
HiplMNTH11·2 decreased ommatidia area (Figures 21 and 22). There was no difference 
between the two full length versions of Hip 1 with mnb and foxo 1, but there was a 
difference between the two truncated versions in ommatidia area (Figures 21 and 22). 
Electron micrographs show the effects of expressing the two genes, mnb and Hip 1, 
together (Figures 21 and 22). These results suggest that mnb and Hipl interact during 
foxol-sensitized eye development to alter the ommatidia area, bristle number and 
ommatidia number compared to controls. 
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Figure 21. Biometric analysis of the interaction between mnb and Hipl during eye 
development along with the GMRGal4 and UASfoxol transgenes in females. Directed 
expression of both full length versions of Hipl , HipJ L-2 and HipJ L-6, the truncated 
versions of Hip] , Hipl AANTH5·2 and Hip] AANTH1u, with mnb in the eye effect 
ommatidia area, bristle and ommatidia number. Micrographs of eyes are shown in A. 
Graphic representations of ommatidia area (n= l 0), bristle number (n= l 0) and ommatidia 
number (n=IO) are shown in B (values represent mean ± SEM). The genotypes are as 
follows: mnb UASmnbEY/4320/+; GMRGal4UASfoxol/+, HiplL-2 UASHipl L-2/+; 
GMRGal4UASfoxol/+, mnb; HiplL-2 UASmnbEY/4320/+; UASHipJ L-2/+; 
GMRGal4UASfoxoll+, HiplL-6 UASHipl L-6/+; GMRGal4UASfoxoll+, mnb; HiplL-6 
UASmnbEr/4320/+; UASHipJ L-6/+; GMRGal4UASfoxol/+, Hip1MNTH5·2 
UASHipJ5·2!GMRGal4UASfoxol, mnb; Hip1MNTH5·2 UASmnbEY/4320/+; 
UASHipJ5·2!GMRGal4UASfoxol, Hip1MNTH11·2 UASHipl 11·2!+; 
GMRGal4UASfoxoll+, mnb; HiplMNTH11•2 UASmnbEr14320!+; UASHip1 11.2/+; 
GMRGal4UASfoxol/+. Bars with dissimilar superscripts indicate groups that differ 
significantly. 
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Figure 22. Biometric analysis of the interaction between mnb and Hipl during eye 
development along with the GMRGal4 and UASfoxol transgenes in males. Directed 
expression of both full length versions of Hip], HiplL-2 and HiplL-6, the truncated 
versions of Hipl, Hip1MNTH5·2 and Hip1MNTH11·2, with mnb in the eye affect 
ommatidia area, bristle and ommatidia number. Micrographs of eyes are shown in A. 
Graphic representations of ommatidia area (n= 1 0), bristle number (n= 1 0) and ommatidia 
number (n=10) are shown in B (values represent mean ± SEM). The genotypes are as 
follows: mnb UASmnbEY/4320/+; GMRGal4UASfoxoll+, HiplL-2 UASHiplL-2/+; 
GMRGal4UASfoxoll+, mnb; HiplL-2 UASmnbEY/4320/+; UASHipl--21+; 
GMRGal4UASfoxoll+, HiplL-6 UASHiplL-6/+; GMRGal4UASfoxol/+, mnb; HiplL-6 
UASmnbEY/4320/+; UASHipJLr6/+; GMRGal4UASfoxol/ +, Hip1MNTH5"2 
UASHipJ 5·2!GMRGal4UASfoxol, mnb; Hip1MNTH5·2 UASmnbEY/4320!+; 
UASHipJ5·2 /GMRGa/4 UASfoxo 1, Hip1MNTH11·2 UASHip 111.2 /+; 
GMRGal4UASfoxol/+, mnb; HiplMNTH/1.2 UASmnbEY/4320/+; UASHipJ 11·2!+; 
GMRGal4UASfoxoll+. Bars with dissimilar superscripts indicate groups that differ 
significantly. 
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Table 5. Comparison of differences in ommatidia area, bristle number 
and ommaditia number when mnb and/or HiplmipJAANTH is expressed along with 
foxol via the GMRGa/4 transgene. 
Ommatidia Bristle Ommatidia 
Comparison Sex Area Number Number 
mnb; Hip/ &-2 F ,_ p < 0.0001 ~ p < 0.0001 NS 
vs. Hip/ fA M ,_ p < 0.0001 ~ p < 0.001 NS 
mnb; Hip l / 6 F NS ~ p < 0.01 NS 
vs. Hipl&-6 M ,_ p < 0.0001 NS NS 
mnb; HiplM NTff·2 F NS ~ p < 0.001 NS 
vs. Hip/M NTH5·2 M NS NS ,_ p < 0.001 
mnb; Hipl!!.ANTH11·2 F ,_ p < 0.001 ~ p < O.OI ,_ p < 0.001 
vs. Hip I MNTHff.2 M NS NS + p < 0 .0001 
mnb;HipJL-2 F ,_ p < 0.001 ~ p < 0.001 ~ p < 0.0001 
vs. mnb M ,_ p < 0.001 ~ p < 0.001 ~ p < 0.0001 
mnb; Hip/ fA F NS ~ p < O.oJ ~ p < 0 .0001 
vs.mnb M NS NS ~ p < 0 .0001 
mnb; Hip/M NTff·2 F NS ,_ p < 0.01 ~ p < O.Ql 
vs. mnb M NS + p < 0.01 ~ p < 0.001 
mnb; Hip!M NTH11·2 F ,_ p < 0.01 ,_ p < 0.01 ,_ p < 0 .0001 
vs. mnb M NS NS + p < 0.0001 
mnb;Hipl L-2 F ,_ p < 0.01 NS NS 
vs. mnb; Hiplfr6 M ,_ p < 0.01 NS NS 
mnb; Hipl!!.ANTff·2 F ~ p < 0.001 NS ~ p < 0.0001 
vs. mnb; Hip/MNTH11·2 M NS + p < 0.01 ~ p < 0 .000 1 
mnb;HipJL-2 F ,_ p < 0.0001 ~ p < 0.0001 ~ p < 0.0001 
vs. mnb; Hipll!.ANTH5·2 M ,_ p < 0.001 ~ p < 0.0001 ~ p < 0.0001 
mnb; Hip/r6 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. mnb; HiplMNTH5·2 M NS ~ p < 0.0001 ~ p < 0.0001 
mnb;Hip l D-2 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. mnb; Hip 1 MNTH/1. 2 M + p < 0.01 ~ p < 0.001 ~ p < 0.0001 
mnb;Hip JD-6 F NS ~ p < 0.0001 ~ p < 0.0001 
vs. mnb; Hip JM NTH/1. 2 M NS NS ~ p < 0.0001 
mnb F ,_ p < 0.01 NS ,_ p < 0.0001 
vs. Hipl f/ 2 M NS NS ,_ p < 0.0001 
mnb F NS NS ,_ p < 0.0001 
vs. HiplfA M ,_ p < 0.0001 NS + p < 0 .0001 
mnb F NS ~ p < 0.0001 ,_ p < 0.01 
vs. HiplMNTJI 2 M NS ~ p < 0.01 ,_ p < 0 .0001 
mnb F NS ~ p < 0.0001 NS 
vs. HipJMNTH11·2 M NS NS ,_ p < 0 .0001 
HiplA F N 
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--------------------------------------------------------------
HiplL-2 F N 
F NS NS NS 
vs. Hip/fA M 1- p < 0.0001 NS NS 
Hipl!l.ANTH5'2 F NS NS 
"' 
p < 0.01 
vs. Hip!MNTH11·2 M NS NS 
"' 
p < 0.01 
Hiplf~2 F NS 
"' 
p < 0.0001 
"' 
p < 0.0001 
vs. Hip!MNTH5·2 M NS 
"' 
p < 0.01 
"' 
p < 0.0001 
HiplA F NS 
"' 
p < 0.0001 
"' 
p < 0 .0001 
vs. Hip!MNTH5'2 M 
"' 
p < 0.0001 
"' 
p < 0.0001 
"' 
p < 0.0001 
Hip/fA F NS 
"' 
p < 0.0001 
"' 
p < 0.0001 
vs. Hipl!l.ANTH11·2 M NS NS 
"' 
p < 0.0001 
HipJ/r6 F NS 
"' 
p < 0.0001 
"' 
p < 0.0001 
Arrows indicate increase (If-) or decrease '+· ( ) in treatment. 
p values based on Neuman-Keuls post-tests 
F= female M= male 
NS= not significant 
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Discussion 
One of the goals of this research was to investigate the role of mnb in Drosophila 
neurogenesis by analysis of the microchaetae bristle formation on the dorsal no tum. The 
original studies of mnb mutants have demonstrated a role for mnb during post-embryonic 
neurogenesis in Drosophila (Tejedor eta/. 1995). However, since its discovery over a 
decade ago, few studies have been done on mnb in Drosophila. Mutant mnb flies with a 
reduction in gene expression show decreased volume of the optic lobes and central brain 
regions in adults and thus it was hypothesized that mnb may have a role in neurogenesis 
during the development of the dorsal no tum. Recent study has indicated a novel role for 
Hip] during Drosophila neurogenesis, where the over-expression of Hip] affects the 
formation of microchaetae bristles (Moores eta/. 2008). As a biochemical interaction 
was found between mnb and Hip] (Kang eta/. 2005), it was imperative to determine if 
this interaction could be involved in the process of mechanosensory bristle formation on 
the dorsal notum. If mnb was found to play a role in bristle formation, this could be a 
source for the biological interaction between mnb and Hipl. No difference in the bristle 
density when mnb is expressed via either apterousGa/4 or pannierGa/4 was determined. 
This suggests that mnb is not the limiting factor in this process. 
The insulin-receptor signalling pathway describes a well-studied mechanism 
whereby cell size, cell number and cell death are regulated (reviewed in Burgering 2008). 
Two components ofthis pathway, akt andfoxol, play opposite roles in this process, with 
akt promoting cell growth, and foxo 1 promoting cell death or cell cycle arrest. The dorsal 
notum has been used as a model to study the role of Notch (Ramain eta/. 2001) and has 
been exploited to show that Hipl plays a role in neurogenesis (Moores eta/. 2008). 
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Although insulin signalling and neurogenesis have both been well-studied, research has 
not investigated the role of these two genes, akt and foxo 1, in Drosophila neurogenesis. 
To study this potential novel role for insulin-receptor signalling components on 
mechanosensory bristle formation, akt and foxo 1 were ectopically expressed in the dorsal 
notum. Considering the important role that akt andfoxo1 play in the growth of cells, it is 
reasonable to think they would play a role in the development of mechanosensory bristle 
cells in the dorsal notum. 
These experiments demonstrate that akt causes an increase in the bristle density 
under the direction of the pannierGa/4 trans gene, to indicate a role for akt in bristle 
formation on the back in females. As akt plays a role in many developmental processes 
(Bhaskar and Hay 2007; Song and Wolfe 2007; Jiang and Lui 2008; Juntilla and 
Koretzky 2008; Tokunaga eta/. 2008), it is reasonable to believe that akt may play a role 
in mechanosensory bristle formation. To the best of my knowledge this is the first time 
that a role for akt in neurogenesis on the Drosophila dorsal notum has been described. An 
increase in the level of akt is sufficient to shift the balance towards neurogenesis, which 
suggests that indeed the insulin signaling pathway is active in the formation of 
mechanosensory bristles on the dorsal notum. 
Whenfoxo1 is expressed in the dorsal notum under the control of the pannierGa/4 
transgene, there is no difference in bristle density compared to the controls, suggesting 
thatfoxo1 does not interfere with neurogenesis. In contrast, over-expression offoxo1 
with apterousGa/4 leads to lethality. Further investigation of the ectopic expression of 
foxo1 will be required to fully understand this finding. 
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During this study it was found that there is no statistical difference in any of the 
phenotypes studied for GFP and lacZ. The fact that there was no difference in these 
controls indicates that either of these genes can be used as controls in future experiments. 
As there is always a question on what controls to use when designing an experiment, this 
study brings useful knowledge to the scientific community as either of these controls will 
yield virtually the same results. 
With minor exceptions, the two full length insertions of the UASHipl and two 
truncated versions of UASHipl transgenes do not give statistically different results from 
each other when over-expressed in the eye with GMR and with GMR andfoxol. This 
suggests that the two independently inserted transgenes do not have different activities. 
Examination of Hipl's ability to influence Drosophila neurogenesis (Moores et al. 2008), 
and Drosophila eye development can certainly add to our understanding of this protein in 
the progression ofHD. 
Studies have suggested a role for Hip 1 as a pro-apoptotic protein, where over-
expression of Hiplleads to caspase-dependent cell death (Hackam eta/. 2000). Hipl 
over-expression with GMR, however, did not show any indication of cell death as bristle 
and ommatidia number were similar to controls. This suggests that although Hipl may 
act to increase apoptosis in cell culture, it does not play this role in live organisms. 
The over-expression offoxol in the developing eye leads to decreased ommatidia 
number, bristle number and ommatidia size (Kramer eta/. 2003) presumably by altering 
aspects of the growth and cell survival signaling mechanisms. Ectopic mnb expression 
has been shown to interact withfoxol in the process of eye development through the 
suppression of the effects offoxol, to result in ommatidia number, bristle number and 
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ommatidia size more similar to controls (Rotchford 2006). Under the sensitized growth 
conditions where the GMRGa/4 drives the foxol transgene, both the full length versions 
and truncated versions of Hipl alter the growth of the eye compared to the controls. The 
full length versions of Hipl show decreased bristle number and decreased ommatidia 
number with no change in ommatidia size compared to the controls. The truncated 
versions of Hipllacking the lipid-binding ANTH domain show normal ommatidia area, 
normal bristle number but decreased ommatidia number. These transgenes lead to 
significantly higher ommatidia number and bristle number than full length Hipl in the 
presence offoxol. These fmdings show that the alternative versions of Hip] can play a 
slightly different role in eye development that is reminiscent of their dual role in 
Drosophila neurogenesis (Moores eta/. 2008). Studies of Hip] in neurogenesis indicate 
that full length Hip 1 decreases microchaetae density and Hip 1 MNTH increases 
microchaetae density (Moores eta/. 2008). The presence or absence of the ANTH 
domain causes two very distinct phenotypes and suggests that Hip 1 may regulate eye 
development through a receptor-mediated endocytotic or vesicle trafficking mechanism, a 
mode similar to that hypothesized for Hipl in neurogenesis (Moores et al. 2008). 
Removal of the ANTH domain of S. cerevisiae 's Sla2P protein causes the protein to lose 
its endocytic ability (Sun et al. 2005), showing the importance of this domain in 
endocytosis. Like Drosophila, humans have multiple protein isoforms of Hip] (Curtis et 
a!. 2005), so it is possible that this dual role of Hip] may occur in humans. This 
mechanism that employs two isoforms of the same protein to have opposing activities 
may be important in understanding the underlying mechanisms that contribute to HD. 
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This is the first account of a role for Hip] being described in Drosophila eye 
development. 
The overexpression of mnb with foxo 1 shows decreased bristle number in males 
and females, and decreased ommatidia number in females. As it interacts withfoxol, it 
was hypothesized that mnb would increase cell growth by preventingfoxol activity. 
These results are inconsistent with the hypothesis and differ from previous results 
obtained for mnb (Rotchford 2006). It is unclear why results vary, but could be due to 
differences in experimental condition or sampling. There may very well be a delicate 
balance between the levels ofmnb andfoxol and further research is needed to fully 
understand the role of mnb in insulin-receptor signaling and development. 
Since both mnb and Hip] have been found to influence eye development under 
sensitized conditions, it is possible that these two genes may interact during this process. 
To investigate this, Hipl and mnb were ectopically expressed along withfoxol and GMR 
in the developing Drosophila eye. Compared to both mnb withfoxol and Hipl with 
foxol as controls, Hip] with mnb andfoxol was found to increase ommatidia area, 
indicative of an increase in cell size. A previous biochemical interaction between Hip 1 
and mnb resulted in the phosphorylation ofHipl by mnb and an increase in the growth of 
neurons (Kang et a/. 2005). This study suggests that a similar role for Hip 1 and mnb may 
be happening in eye development to increase the growth of ommatidia. When compared 
to Hipl withfoxol controls, all versions of Hipl with mnb andfoxol were found to 
decrease the number of bristles formed. This suggests that mnb increases the ability of 
Hipl to decrease neurogenesis. Alternatively, when compared to mnb withfoxol, both 
full length versions of Hipl were found to decrease the bristle number, whereas the 
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truncated versions on Hip] increased the bristle number. This indicates that the two 
different versions of Hip] act differently with mnb, with the full length version 
decreasing neurogenesis and the truncated version increasing neurogensis. This is 
reminiscent of the role that Hip] plays in Drosophila neurogenesis in the dorsal noturn 
(Moores et al. 2008). Compared to the truncated verions of Hip] withfoxol, the 
truncated versions of Hipl with mnb andfoxol show a decrease in ommatidia number, 
with the full length Hipl having no effect. It is possible that mnb is influencing the 
truncated version only in the process of cell growth, but does not influence full length 
Hipl in this process. When compared to mnb withfoxol controls, both the full length 
versions and Hip1MNTH5·2 increased ommatidia number, while Hip1MNTH11·2 
decreased ommatidia area. The two versions of Hip] may be influencing the activity of 
mnb, but appear to be doing so differentially. 
It is clear that mnb and Hip] are interacting during the process offoxol-sensitized 
eye development. As mnb has been shown to interact withfoxol and participate in the 
insulin signaling pathway, it could be that Hipl participates in this pathway as well. As 
little research has been done on Hipl, it is possible that participation in the insulin 
signaling pathway could be a novel role for Hipl. A second source for their interaction 
could be during receptor mediated endocytosis. It has been thought for the last two 
decades that mnb over-expression may alter receptor-mediated endocytosis (Wegiel et al. 
2004). More specifically, mnb is thought to be involved in synaptic vesicle recycling and 
synaptic signal transmission by phosphorylating dynarnin (Wegiel et al. 2004). Hipl has 
also been found to play a role in endocytosis, by binding to components of the endocytic 
apparatus, such as the adapter protein AP2, the heavy and light chains of the triskelia and 
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the lipid membrane via the ANTH domain (Metzler eta/. 2001; Chen and Brodsky 2005). 
It is likely that Hip 1 and rnnb are interacting during receptor mediated endocytosis during 
the process of eye development. 
Overall, this study has shown that akt andfoxol may play a role in bristle 
development in the dorsal no tum, adding to the understanding of the insulin signaling 
pathway and its components. Hipl has a role in the process of Drosophila eye 
development, similar to the role found in Drosophila neurogenesis. Duringfoxol-
sensitized eye development, rnnb and Hipl interact to influence cell size and cell number. 
Drosophila has proven to be a useful model to study these genes and how they interact in 
a living organism. In the future, Drosophila melanogaster will continue to be useful for 
studying the genes of diseases like Down syndrome and Huntington disease, a 
neurogenerative disease and neurodegenerative disease in humans. As these are genes in 
two completely different diseases, finding how they interact could provide a key insight 
into fmding therapies for neurodegenerative diseases. 
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Go: 
G1: 
G2: 
Appendix 1 
a w: UCyO: UASHip1 L-2fTM3.Sb 
b w: UCyO: UASHip1 L-6fTM3.Sb 
a w: +/CyO: UASHip1 L-2fTM6B 
b w: +/CyO: UAS Hip1 L-6fTM6B 
a w: UASHip1 L-2fTM6B 
b w: UASHip1 L-6fTM6B 
X 
l 
X 
l 
X 
l 
w; Ly!TM68 
a w: +/CyO: UASHip1 L-2fTN. 
b w: +/CyO: UASHip1 L-6fTM 
a w: UASHip1L·2/TM6B 
b w: UASHip1 L-6fTM6B 
Stock 
a w: UASHip1 L-2fTM6B 
b w: UASHip1 L-6fTM6B 
Schematic diagram for crosses made to eliminate the second chromosome balancer. w; 
UASHiplL-2/TM6B was generated in a and b shows w; UAS Hip1L-6/TM6B. 
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